Th1/Th2 Imbalance and Elevated PD-L1 in Pleural Effusion Predict the Risk of Multi-Drug Resistant Tuberculous Pleuritis
Authors
Abstract:
Background: Patient immune status might be indicative of the variance in bacterial genetics in drug-resistant tuberculous pleuritis and could be used for predicting the risk of multi-drug resistant tuberculous pleuritis (MDR-TB). Objective: To determine the significance of Th2/Th1 ratio and concentration of PD-L1 in the pleural effusions for prediction of MDR-TB. Methods: We measured the ratio of Th2 to Th1 T cells from pleural effusions in 373 tuberculous pleuritis patients. We also measured the concentration of programmed death ligand-1 (PD-L1) in the pleural effusions of these patients. Afterwards, we determined the optimal cut-off value for predicting the occurrence of multi-drug resistant tuberculous based on the Youden index, diagnostic evaluation test, and receiver operation curve. Multiple logistic analysis was employed to identify the independent risk factors for MDR-TB occurrence. Results: The area under the curve (AUC) of the Th2 to Th1 ratio was 0.66 and the concentration of PD-L1 was 0.71. Based on the combined detection of PD-L1 concentration in pleural effusion and the Th2 to Th1 ratio, our AUC was 0.81 and had a specificity of 0.92. Only a combined detection was able to identify patients developing multidrug-resistant tuberculosis. Multiple logistic analysis showed that a high concentration of PD-L1 and a high Th2 to Th1 T ratio in pleural effusions were indicative of an immunocompromised status. Therefore, these measurements might be independent risk factors for the occurrence of multidrug-resistant tuberculous. Conclusion: Evaluation of immune status based on PD-L1 pleural concentration and Th2 to Th1 ratio might predict the risk of MDR-TB occurrence.
similar resources
Tuberculous pleural effusion.
Tuberculous pleural effusion occurs in approximately 5% of patients with Mycobacterium tuberculosis (TB) infection1 and accounts for 4% of all TB cases in the United States.2 Diagnosis is challenging, with 48–96% of tuberculous pleural effusions negative by sputum acid-fast bacilli (AFB) stain and culture. Thoracentesis is frequently performed and shows an exudative, lymphocytic pleural effusio...
full textTuberculous Pleural Effusion
Tuberculosis (TB) has traditionally been one of the major causes of pleural disease and until the earlier decades of the past century held as a principal paradigm of “pleuritis”. Indeed in the presence of a distinctly exudative effusion and a compatible clinical presentation the widely used term “pleuritis exudativa” insinuated a tuberculous aetiology and has therefore been understood to be syn...
full textTuberculous Pleural Effusion.
When a patient presents with new pleural effusion, the diagnosis of tuberculous (TB) pleuritis should be considered. The patient is at risk for developing pulmonary or extrapulmonary TB if the diagnosis is not made. Between 3% and 25% of patients with TB will have TB pleuritis. The incidence of TB pleuritis is higher in patients who are human immunodeficiency virus (HIV)-positive. Pleural fluid...
full textTuberculous Pleural Effusion
Pleural effusions are a common finding in emergency departments, with cytologic analysis traditionally required for definitive diagnosis. This article describes a classic sonographic appearance of tuberculous pleural effusion.
full textTuberculous Pleural Effusion in Children
Background and Aim: Pleural effusion is the second most common type of extra pulmonary tuberculosis with an incidence of 4.9%. This study aims to describe the age distribution, main clinical, laboratory and radiographic findings and outcome of patients with Tuberculous Pleural Effusion (TPE). Materials and Methods: This is a retrospective study of TPE patients admitted in pediatric ward of Masi...
full textMy Resources
Journal title
volume 17 issue 1
pages 1- 13
publication date 2020-03-01
By following a journal you will be notified via email when a new issue of this journal is published.
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023